Latest Compliance News

American Uranium Limited has upgraded its U.S. trading status to the OTCQB Venture Market, enhancing liquidity and accessibility for North American investors. This move supports the company’s strategy to expand its U.S. shareholder base and increase visibility for its flagship uranium project in Wyoming.

Acusensus Limited has expanded its multi-function enforcement contract with the Western Australian Road Safety Commission, doubling its trailer-based units and extending the contract through to 2028.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Amotiv Limited reported a 3.3% revenue increase to $520.5 million for the half year ended December 2025, alongside a 39.4% jump in net profit, driven by new business wins and operational efficiencies despite margin pressures in key segments.

Queste Communications reported a slight operating cash outflow in January 2026 but ended the month with a solid cash position supported by financing activities and investments.

Teaminvest Private Group Limited has extended its on-market share buy-back program for another year, allowing the company to repurchase up to 10% of its issued shares without shareholder approval.

Reach Resources reports exceptional metallurgical test results from its Murchison South Gold Project, highlighting high gold recoveries and favourable processing characteristics that support toll milling potential.

Celsius Resources Limited has had its trading suspension lifted following an announcement about its Supreme Court application challenging the validity of its prior auditor's 2011 resignation.

Celsius Resources has secured a Supreme Court order validating its auditor appointment and prior share issues, paving the way for its shares to be reinstated on the ASX.

Western Gold Resources has taken a decisive step towards production at its Gold Duke Project by awarding pre-mining contracts and appointing SSH Mining as the mine operator, setting the stage for Q1 2026 mobilisation.

Cannindah Resources has successfully raised over $11 million through the first tranche of its share placement, with the second tranche awaiting shareholder approval in March 2026.

Paradigm Biopharmaceuticals has entered a binding agreement with AVet Health to co-develop and license a novel oral therapy for veterinary osteoarthritis in Australia and New Zealand, unlocking new market potential while advancing its human clinical trials.